Novel Agent Eases BPH-Related LUTS
PARIS—Ozarelix, an investigational agent, may be effective for selected men with lower urinary tract symptoms (LUTS) associated with BPH, phase II trial data suggest. The drug is a highly soluble luteinizing hormone releasing antagonist.
The e-mail address(es) that you supply to use this service will only be used to send the requested article.